PHIBRO ANIMAL HEALTH CORP

For the period ended Mar 31, 2024. Filed May 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 8, 2024

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations


· · Three Months · · Nine Months
For the Periods Ended March 31 · 2024 · 2023 · 2024 · 2023 ·
· · (unaudited) ·
· · (in thousands, except per share amounts) ·
Net sales	$263,223	$245,673	$744,515	$722,840
Cost of goods sold	183,623	170,133	518,573	501,269
Gross profit	79,600	75,540	225,942	221,571
Selling, general and administrative expenses	59,676	56,987	191,043	173,490
Operating income	19,924	18,553	34,899	48,081
Interest expense, net	4,575	3,871	13,798	10,822
Foreign currency losses (gains), net	2,427	(422)	16,593	4,629
Income before income taxes	12,922	15,104	4,508	32,630
Provision for income taxes	4,517	5,062	2,844	11,522
Net income	$8,405	$10,042	$1,664	$21,108

Net income per share
basic	$0.21	$0.25	$0.04	$0.52
diluted	$0.21	$0.25	$0.04	$0.52
Weighted average common shares outstanding
basic	40,504	40,504	40,504	40,504
diluted	40,520	40,504	40,509	40,504

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.